AMPK activation by dihydrotestosterone reduces FSH-stimulated cell proliferation in rat granulosa cells by inhibiting ERK signaling pathway

Endocrinology

Volumn 153, Issue 6, 2012, Pages 2831-2838

  Kayampilly, Pradeep P ^a   Menon, K M J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ANDROSTANOLONE; CYCLIN D2; ESTRADIOL; FOLLITROPIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FEMALE; GRANULOSA CELL; HORMONE ACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AMP-ACTIVATED PROTEIN KINASES; ANDROGENS; ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D2; DIHYDROTESTOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FOLLICLE STIMULATING HORMONE; GENE EXPRESSION; GRANULOSA CELLS; HORMONES; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 84861326693     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1967     Document Type: Article

References (38)

1. Channing CP, Schaerf FW, Anderson LD, Tsafriri A 1980 Ovarian follicular and luteal physiology. Int Rev Physiol 22:117-201
2. Rao MC, Midgley Jr AR, Richards JS 1978 Hormonal regulation of ovarian cellular proliferation. Cell 14:71-78 (Pubitemid 8340435)
3. Hirshfield AN 1991 Development of follicles in the mammalian ovary. Int Rev Cytol 124:43-101
4. Fortune JE, Armstrong DT 1977 Androgen production by theca and granulosa isolated from proestrous rat follicles. Endocrinology 100: 1341-1347 (Pubitemid 8094054)
5. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar- Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF 2006 Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91:4237-4245
6. Stewart PM, Shackleton CH, Beastall GH, Edwards CR 1990 5α- Reductase activity in polycystic ovary syndrome. Lancet 335:431-433 (Pubitemid 20054649)
7. Agarwal SK, Judd HL, Magoffin DA 1996 A mechanism for the suppression of estrogen production in polycystic ovary syndrome. J Clin Endocrinol Metab 81:3686-3691 (Pubitemid 26339938)
8. Jakimiuk AJ, Weitsman SR, Magoffin DA 1999 5α-Reductase activity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 84:2414-2418
9. Fassnacht M, Schlenz N, Schneider SB, Wudy SA, Allolio B, Arlt W 2003 Beyond adrenal and ovarian androgen generation: increased peripheral 5α-reductase activity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:2760-2766 (Pubitemid 36724453)
10. Magoffin DA 2006 Ovarian enzyme activities in women with polycystic ovary syndrome. Fertil Steril 86(Suppl 1):S9-S11
11. Kayampilly PP, Wanamaker BL, Stewart JA, Wagner CL, Menon KMJ 2010 Stimulatory effect of insulin on 5α-reductase type 1 (SRD5A1) expression through an Akt-dependent pathway in ovarian granulosa cells. Endocrinology 151:5030-5037
12. Pradeep PK, Li X, Peegel H, Menon KMJ 2002 Dihydrotestosterone inhibits granulosa cell proliferation by decreasing the cyclin D2 mRNA expression and cell cycle arrest at G1 phase. Endocrinology 143:2930-2935 (Pubitemid 34809865)
13. Richards JS, Russell DL, Ochsner S, Hsieh M, Doyle KH, Falender AE, Lo YK, Sharma SC 2002 Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization. Recent Prog Horm Res 57:195-220
14. Alam H, Maizels ET, Park Y, Ghaey S, Feiger ZJ, Chandel NS, Hunzicker-Dunn M 2004 Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/ AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. J Biol Chem 279: 19431-19440 (Pubitemid 38623376)
15. Kayampilly PP, Menon KMJ 2004 Inhibition of extracellular signal-regulated protein kinase-2 phosphorylation by dihydrotestosterone reduces follicle-stimulating hormone-mediated cyclin D2 messenger ribonucleic acid expression in rat granulosa cells. Endocrinology 145:1786-1793 (Pubitemid 38402387)
16. Hunzicker-Dunn M, Maizels ET 2006 FSH signaling pathways in immature granulosa cells that regulate target gene expression: branching out from protein kinase A. Cell Signal 18:1351-1359 (Pubitemid 43832089)
17. Kayampilly PP, Menon KMJ 2007 Follicle-stimulating hormone increases tuberin phosphorylation and mammalian target of rapamycin signaling through an extracellular signal-regulated kinase-dependent pathway in rat granulosa cells. Endocrinology 148:3950-3957 (Pubitemid 47105853)
18. Kayampilly PP, Menon KMJ 2009 Follicle-stimulating hormone inhibits adenosine 5′-monophosphate-activated protein kinase activation and promotes cell proliferation of primary granulosa cells in culture through an Akt-dependent pathway. Endocrinology 150: 929-935
19. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2[-ΔΔ C(T)] Method. Methods 25:402-408 (Pubitemid 34164012)
20. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, Hardie DG 1996 Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271:27879-27887 (Pubitemid 26367365)
21. Stein SC, Woods A, Jones NA, Davison MD, Carling D 2000 The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 345(Pt 3):437-443 (Pubitemid 30099070)
22. Kayampilly PP, Menon KMJ 2006 Dihydrotestosterone inhibits insulin- stimulated cyclin D2 messenger ribonucleic acid expression in rat ovarian granulosa cells by reducing the phosphorylation of insulin receptor substrate-1. Endocrinology 147:464-471 (Pubitemid 43004301)
23. Sullivan JE, Brocklehurst KJ, Marley AE, Carey F, Carling D, Beri RK 1994 Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett 353:33-36 (Pubitemid 24312538)
24. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE 2001 Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174 (Pubitemid 32995375)
25. Oakhill JS, Steel R, Chen ZP, Scott JW, Ling N, Tam S, Kemp BE 2011 AMPK is a direct adenylate charge-regulated protein kinase. Science 332:1433-1435
26. Hardie DG 2011 Sensing of energy and nutrients by AMP-activated protein kinase. Am J Clin Nutr 93:891S-896S
27. Steinberg GR, Kemp BE 2009 AMPK in health and disease. Physiol Rev 89:1025-1078
28. Kahn BB, Alquier T, Carling D, Hardie DG 2005 AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1:15-25 (Pubitemid 43960587)
29. Horman S, Vertommen D, Heath R, Neumann D, Mouton V, Woods A, Schlattner U, Wallimann T, Carling D, Hue L, Rider MH 2006 Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase α-subunits in heart via hierarchical phosphorylation of Ser485/491. J Biol Chem 281:5335-5340 (Pubitemid 43847626)
30. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers JD, Eppig JJ, Bronson RT, Elledge SJ, Weinberg RA 1996 Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384:470-474 (Pubitemid 26414665)
31. Robker RL, Richards JS 1998 Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1. Mol Endocrinol 12:924-940 (Pubitemid 30660661)
32. Igata M, Motoshima H, Tsuruzoe K, Kojima K, Matsumura T, Kondo T, Taguchi T, Nakamaru K, Yano M, Kukidome D, Matsumoto K, Toyonaga T, Asano T, Nishikawa T, Araki E 2005 Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Circ Res 97:837-844 (Pubitemid 41447135)
33. Imamura K, Ogura T, Kishimoto A, Kaminishi M, Esumi H 2001 Cell cycle regulation via p53 phosphorylation by a 5′-AMPactivated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-β-Dribofuranoside, in a human hepatocellular carcinoma cell line. Biochem Biophys Res Commun 287:562-567 (Pubitemid 32917636)
34. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, Thompson CB 2005 AMP-activated protein kinase induces a p53- dependent metabolic checkpoint. Mol Cell 18:283-293 (Pubitemid 41350534)
35. Das S, Maizels ET, DeManno D, St Clair E, Adam SA, Hunzicker- Dunn M 1996 A stimulatory role of cyclic adenosine 3′,5′-monophosphate in follicle-stimulating hormone-activated mitogen-activated protein kinase signaling pathway in rat ovarian granulosa cells. Endocrinology 137:967-974
36. Cottom J, Salvador LM, Maizels ET, Reierstad S, Park Y, Carr DW, Davare MA, Hell JW, Palmer SS, Dent P, Kawakatsu H, Ogata M, Hunzicker-Dunn M 2003 Follicle-stimulating hormone activates extracellular signal-regulated kinase but not extracellular signal-regulated kinase kinase through a 100-kDa phosphotyrosine phosphatase. J Biol Chem 278:7167-7179 (Pubitemid 36800716)
37. Kim J, Yoon MY, Choi SL, Kang I, Kim SS, Kim YS, Choi YK, Ha J 2001 Effects of stimulation of AMP-activated protein kinase on insulin-like growth factor 1- and epidermal growth factor-dependent extracellular signal-regulated kinase pathway. J Biol Chem 276:19102-19110
38. Wang W, Guan KL 2009 AMP-activated protein kinase and cancer. Acta Physiol (Oxf) 196:55-63